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Abstract
Prostaglandins (PGs) play a number of roles in the kidney, including regulation of salt and water reabsorption.
In this report, evidence was obtained for stimulatory effects of PGs on Na-K-ATPase in primary cultures of
rabbit renal proximal tubule (RPT) cells. The results of our real-time PCR studies indicate that in primary
RPTs the effects of PGE2, the major renal PG, are mediated by four classes of PGE (EP) receptors. The role of
these EP receptors in the regulation of Na-K-ATPase was examined at the transcriptional level. Na-K-ATPase
consists of a catalytic α-subunit encoded by the ATP1A1 gene, as well as a β-subunit encoded by the ATP1B1
gene. Transient transfection studies conducted with pHβ1-1141 Luc, a human ATP1B1 promoter/luciferase
construct, indicate that both PGE1 and PGE2 are stimulatory. The evidence for the involvement of both the
cAMP and Ca2+ signaling pathways includes the inhibitory effects of the myristolylated PKA inhibitor PKI,
the adenylate cyclase (AC) inhibitor SQ22536, and the PKC inhibitors Gö 6976 and Ro-32-0432 on the
PGE1 stimulation. Other effectors that similarly act through cAMP and PKC were also stimulatory to
transcription, including norepinephrine and dopamine. In addition to its effects on transcription, a chronic
incubation with PGE1 was observed to result in an increase in Na-K-ATPase mRNA levels as well as an
increase in Na-K-ATPase activity. An acute stimulatory effect of PGE1 on Na-K-ATPase was observed and was
associated with an increase in the level of Na-K-ATPase in the basolateral membrane.
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Abstract 
 
 Prostaglandins (PGs) play a number of roles in the kidney, including regulation of salt 
and water reabsorption. In this report evidence was obtained for stimulatory effects of 
PGs on Na,K-ATPase in primary cultures of rabbit renal proximal tubule (RPT) cells.   
The results of our RealTime PCR studies indicate that in primary RPTs the effects of 
PGE2, the major renal PG, are mediated by 4 classes of PGE (EP) receptors.  The role of 
these EP receptors in the regulation of Na,K-ATPase was examined at the transcriptional 
level. Na,K-ATPase consists of a catalytic α subunit encoded by the ATP1A1 gene, as 
well as a β subunit encoded by the ATP1B1 gene.  Transient transfection studies 
conducted with pHß1-1141 Luc, a human ATP1B1 promoter/luciferase construct, 
indicate that both PGE1 and PGE2 are stimulatory.  The evidence for the involvement of 
both the cAMP and Ca2+ signaling pathways includes the inhibitory effects of the 
myristolylated protein kinase A  (PKA) inhibitor PKI, the adenylate cyclase (AC) 
inhibitor SQ22536, and the Protein Kinase C (PKC) inhibitors Gö 6976 and Ro-32-0432 
on the PGE1 stimulation.  Other effectors that similarly act through cAMP and PKC were 
also stimulatory to transcription, including norepinephrine and dopamine. In addition to 
its effects on transcription, a chronic incubation with PGE1 was observed to result in an 
increase in Na,K-ATPase mRNA levels as well as an increase in Na,K-ATPase activity. 
An acute stimulatory effect of PGE1 on Na,K-ATPase was observed, and was associated 
with an increase in the level of Na,K-ATPase in the basolateral membrane. 
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Introduction      
     
     Prostaglandins (PGs) are involved in mediating the response of the kidney to changes 
in Na+ balance, by regulating renal ion transport, glomerular filtration, renin release, and 
blood flow (9, 32, 61). The ultimate effect of PGs is on blood pressure (45).  The specific 
effects of PGs on the nephron have been difficult to define by means of renal clearance 
studies, because PGs are potent vasodialators (61).  Thus, many of the previous studies 
with PGs were conducted with isolated perfused tubules (9).  These studies have been 
concerned with the acute effects of PGs (9).   
 
    The results of the studies with isolated perfused tubules have clearly indicated that PGs 
do indeed affect transport in different nephron segments, although each nephron segment 
responds to PGs in a distinctive manner (9). For example, a15 min incubation with PGE2 
inhibited Na+ transport across the rabbit cortical collecting tubule (CCT) while having no 
effect on the rabbit medullary thick ascending limb (15), (35). A consequence of the 
inhibition of Na+ transport in the CCT was natriuresis.  The acute inhibition of Na+ 
reabsorption in the CCT is associated with a reduction in Na, K-ATPase activity (57), 
unlike the acute stimulatory effect of PGs on distal tubule Na,K-ATPase (57). In contrast 
to the extensive studies of acute PG effects, chronic PGs effects have not been conducted 
with isolated nephron segments, due to their limited viability.  
 
     For this reason, we have studied long-term effects of PGs on growth and transport 
using kidney epithelial cell culture systems.  When studying the MDCK cell line, we 
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observed that both PGE1 and 8Br-cAMP increased the activity of the Na,K-ATPase (67). 
The Na,K-ATPase consists of both an α subunit (with catalytic activity) and a β subunit, 
involved in insertion of Na,K-ATPase in the basolateral membrane.  The level of both the 
α and the β subunits increased in PGE1 and 8BrcAMP treated MDCK cells. In addition, 
the level of the mRNAs for the α1 and the ß1 subunit also increased (65).  However, the 
level of ß1 subunit mRNA increased to a larger extent than α1 subunit mRNA,  Thus in 
our initial studies, the regulation of transcription of the ß1 subunit gene (ATP1B1) was 
examined in detail, and the signal transduction pathways involved in β subunit gene 
transcription were defined (65).  Evidence was obtained for the involvement of Protein 
Kinase A and Protein Kinase C. 
 
     However, it was unclear whether the signal transduction pathways involved in the 
regulation of ATP1B1 transcription are unique to MDCK cells, which serve as a distal 
tubule model, or whether tubule epithelial cells in other nephron segments are subject to 
similar types of control.   The renal proximal tubule (RPT) is of particular interest in 
these regards because this nephron segment is involved in the response of the kidney to 
changes in Na+ status (3).  A number of hormones and other effectors mediate the 
response of the kidney to such changes, including PGs (21). 
 
     To study PG effects on the RPT, we have employed a primary rabbit RPT cell culture 
system, which closely resembles normal RPTs in the animal (62, 63). The primary RPT 
cells possess a polarized morphology, as well as transport systems which are involved in 
polarized solute transport,  including an apical Na+/glucose cotransport system (SGLT1) 
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(14, 54), a basolateral p-Aminohippurate (PAH) transport system (OAT1) (72) (14, 30, 
36), and a Na+/Phosphate cotransport system (Npt2) (70) .   In addition, the cultures 
respond to Parathyroid Hormone (PTH) (14), insulin (69), dopamine (31),  and 
Angiotensin II (Ang II) (29)  in a manner that is characteristic of RPT cells.   Ang II 
stimulates the synthesis of PGs (1) including PGE2, PGF2α, and 6-keto-PGF 1α (1).  
 
     In this report effects of PGs on Na, K-ATPase in the primary RPT cell cultures are 
examined. In order to determine whether the observed increase in the Na,K-ATPase ß1 
subunit following treatment with PGE1 can be explained by transcriptional regulation, 
transient transfection studies were conducted with pHß1-1141 Luc, a human Na,K-
ATPase ß1 promoter/Luciferase construct (22).   The involvement of both Protein Kinase 
A (PKA) and Protein Kinase C (PKC) in signaling has been examined. In addition, the 
effects of Arachidonic Acid (AA) and its metabolites, norepinephrine and dopamine have 
been studied because these effectors, like PGs, are produced in response to changes in 
Na+ balance.  In order to evaluate the physiologic significance, both the acute and chronic 
affects of PGs on Na,K-ATPase activity have been examined. 
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Materials and Methods 
 
Materials  
      Hormones, human transferrin, PGs, and other chemicals were from Sigma Aldrich 
Chemical Corp (St. Louis, Mo.).  PKC inhibitors were from Calbiochem (La Jolla, 
Calif.). PG receptor agonists and antagonists were from Cayman Chemical (Ann Arbor, 
Mich.).  Dulbecco’s Modified Eagle’s Medium (DME), Ham’s F12 Medium (F12), 
soybean trypsin inhibitor, and lipofectamine were from Invitrogen Corp. (Carlsbad, 
Calif.). Class IV collagenase was from Worthington (Freehold, NJ). Mouse monoclonal 
antibodies against the Na,K-ATPase α1  (sc-21712), ß1 subunit (sc-21713) and goat anti-
mouse horse radish peroxidase conjugate were from Santa Cruz Biotech (Santa Cruz, 
Calif.).  Immun-Star HRP Substrate, nitrocellulose, acrylamide, and other electrophoresis 
reagents were from Bio-Rad Corp. (Hercules, Calif.). Streptavidin sepharose beads were 
from Amhersham Corp.  The Galacto-Star System was obtained from Applied 
Biosystems (Bedford, Mass.).  Both the p-SV ß-galactosidase (pSVßgal) plasmid, and 
Reporter Lysis Buffer were from Promega Corp. (Madison, Wisc).  The Prism 5 program 
was obtained from Graph Pad Software, Inc. (San Diego, Calif.).  86Rb+ (>1 µCi/µg) was 
obtained from Perkin Elmer Corp. , Billerica, Ma).  Transwells were obtained from 
Corning, Inc. (Corning, NY). 
 
Primary RPT Cultures 
      The basal medium for primary RPT cells consists of a 1:1 mixture of Dulbecco’s 
Modified Eagle’s Medium (DME) and Ham’s F12 medium (F12) (pH 7.4) containing 15 
mM HEPES, 20 mM Na+ bicarbonate, penicillin (92 units/ml) and kanamycin (0.01%) 
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(DME/F12) (14).  Immediately prior to use, the medium was further supplemented with 
bovine insulin (5 µg/ml), human transferrin (5 µg/ml), 50 nM hydrocortisone (Medium 
RK1), and, if appropriate, other factors(14). Water used for medium and growth factor 
preparations was purified using a Milli-Q deionization system. Iron oxide in 0.9% NaCl 
was prepared, sterilized in an autoclave, and diluted with PBS prior to use (18). 
 
     To initiate primary rabbit kidney proximal tubule (RPT) cell cultures (14, 36), a 
kidney from a male, New Zealand White rabbit (2-2.5 kg) was perfused via the renal 
artery, first with Phosphate Buffered Saline (PBS), and subsequently with sterile 0.5% 
(w/v) iron oxide.  The renal cortex was sliced, homogenized with a sterile Dounce 
homogenizer (loose pestle), and the homogenate (consisting of nephron segments) was 
sequentially passed through a 253 µ and an 83 µ mesh.  The renal proximal tubules and 
the glomeruli on the 83 µ mesh were transferred into a 50 ml conical tube containing 
DME/F12, and a sterile stir bar. The glomeruli (with bound iron oxide) were removed 
with the stir bar, resulting in a preparation of tubules that stained positively for γ-
glutamyltranspeptidase (γGT) (Taub, unpublished), a distinctive RPT marker.  
 
Tubules to be utilized for primary cultures were treated with 0.05 mg/ml collagenase in 
DME/F12 containing .5 µg/ml soybean trypsin inhibitor for 2 min at 23o C.  The tubules 
were washed twice by centrifugation, resuspended in DME/F12, and plated in 35 mm 
dishes containing Medium RK-1.  The medium was changed the day after plating and 
every 2 days thereafter.   
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Transient Transfection Studies 
     Primary cultures were cotransfected with pHß1-1141 Luc, a human ß1 subunit 
promoter/luciferase construct (1 µg), and the pSVßgal plasmid (0.2 µg), to correct for 
transfection efficiency.  Transfections were carried out utilizing lipofectamine in 
antibiotic free DME/F12 supplemented with 5 µg/ml insulin and 5 µg/ml transferrin.  The 
next day, the medium was changed to antibiotic containing DME/F12 supplemented with 
5 µg/ml insulin and 5 µg/ml transferrin. ,  The cultures were incubated for 2 hrs in a 
humidified 5% CO2/95% air humidified environment, and then treated with appropriate 
effectors for 4 hrs (unless otherwise indicated). Four cultures were used per condition to 
maintain accuracy of determinations of +/- 10-20%. At the end of the incubation, the 
monolayers were solubilized in Reporter Lysis Buffer, and spun for 1 minute at 13,600 x 
g in a microcentrifuge.  The cell lysates were then assayed for luciferase and β 
galactosidase (β gal) activity. 
 
     To measure luciferase activity, an aliquot of the cell lysate was placed in 0.1 ml a 
buffer containing 20 mM Tricine, 1.07 mM (MgCO3) . 4Mg(OH)2, 2.67 mM MgSO4, 0.1 
mM EDTA, 33.3 mM dithiothreitol, 270 µM Coenzyme A, 470 µM luciferin and 530 µM 
ATP.  The light units emitted were determined using a Packard Tricarb 4530 scintillation 
counter with the coincidence circuit turned off.  As a control in these studies, luciferase 
activity was determined as a function of light emitted per unit of luciferase activity, using 
purified firefly luciferase (Sigma/Aldrich Corp).   Luciferase determinations were made 
within light units in which activity was linear as a function of increasing luciferase 
 9 
activity  (which was obtained with activity measurements giving no more than 3.1 x 106 
cpm). Luciferase determinations were made with 3-6 day old cultures.  
 
     To determine ß-gal activity, aliquots of cell lysates were incubated in a reaction buffer 
containing the Galacton-Star® substrate (a component of the Galacto-StarTM System).  
The light emitted was measured as described above.   ß-gal activity was expressed as a 
fraction of the activity in Control transfected cultures.  As a control ß-gal activity was 
determined as a function of increasing levels of purified ß-gal activity. ß-Gal 
determinations were after a 90-120 min incubation, during which time the activity was 
constant.  ß-Gal determinations conducted within a range, in which the activity was 
constant as a function of increasing ß-gal activity (for activity levels giving 
measurements of up to 2 x 106 cpm).  
 
     Each luciferase determination was normalized with respect to ß-gal activity.  For each 
condition a luciferase value was obtained by calculating the average of quadruplicate 
determinations (+/- the Standard Error of the Mean (SEM)).  This average value was 
compared to the Control value (obtained with cultures maintained with insulin and 
transferrin alone).  Both  a One Way analysis of variance (ANOVA), and the Newman-
Keuls Multiple Comparison Test (using Prism 5 software) were employed to determine 
the statistical significance of the results.  Differences were determined to be significant 
when p< 0.05.  The effects of regulatory molecules on luciferase and ß-gal activity were 
determined in at least 2 independent culture sets.   
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RealTime PCR 
 
     Primary RPT cell cultures were treated with appropriate effector molecules. RNA was 
purified from the cultures using an RNA -4PCR kit (Ambion). Genomic DNA was first 
removed using TURBO DNAase I (Ambion), and then cDNA was synthesized from the 
purified RNA using reverse transcriptase.  Transcripts were amplified in a BioRad I 
Cycler using iQ Sybr Green Supermix, as well as 5 µM forward and reverse primers 
complementary to appropriate template on the cDNA.  After amplification Ct values were 
calculated using the Bio-Rad IQ5 program. The relative mRNA levels were quantitated 
from using the Pfaffl method (50). GAPDH mRNA was used as an internal control in the 
calculations of relative mRNA levels. 
 
The primers were designed by using the Primer-BLAST Primer designing tool on the 
NCBI website, and synthesized by Invitrogen. Included amongst the cDNAs used for 
primer design are rabbit EP1 (Accession Number AF043491.1, PTGER1), 
AGAGGCCCAATCGGTTAAGT, AGCTTCATTTACCCTCGCAA; rabbit EP2 
(Assession Number NM_001082659, PTGER2), CTGCAGCATCTGGAAGATCA, 
CATGGGCTCCTTGAGGATAA; rabbit EP3 (Assession Number NM_001122935.1, 
PTGER3), TAATAGCTGTTCGCCTGGCT, GACGTTCCTGTTCTCACGCT; rabbit 
EP4 (Assession Number NM_001082259.1, PTGER4), 
CACCTACATGAAGGGCCAGT, GGCTGTAGAAGTAGGCGTGG; rabbit ATP1A1 
(Assession Number AF235024, ATP1A1_RABIT), TGACTCTCCTGCTCTGAAG, 
CACAATGGAAGCGAAGTTATC; rabbit ATP1B1 (Assession Number AF204927, 
ATP1B1_RABIT), ACTGGCAAGCGAGATGAAG, ATGGTGAGGTTGGTGAACTG; 
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and rabbit GAPDH (Assession Number L23961, RABGLY3PHO), 
GCCCTCAATGACCACTTTGT, TCATGACAAGGTAGGGCTCC.  
 
Preparation of Cell Lysates from Cultures on Polystyrene 
     To determine the effect of exogenous PG and other effectors on Na,K-ATPase levels, 
primary RPT monolayers were grown in Medium RK-1 containing 10-6 M indomethacin, 
to inhibit endogenous PG biosynthesis.  The cultures were treated on a daily basis for 4 
days with effector molecules, also in the presence of indomethacin. Cell lysates were 
prepared by first washing the RPTs twice with ice-cold PBS at 4o C, and then solubilizing 
the monolayers in lysis buffer (20 mM Tris, pH 7.5, 1% Triton X-100, 120 mM NaCl, 1 
mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMFS), 1 µg/ml aprotinin, 1 µg/ml 
leupeptin, 1 µg/ml pepstatin, 1 mM Na+ orthovanadate and 1 mM NaF). The cell lysates 
were transferred from the culture dishes into microfuge tubes, using a rubber policeman.  
 
Cell Surface Biotinylation Studies 
     Rabbit kidney proximal tubules were plated on Transwell inserts (24 mm, 0.4 µm 
polycarbonate membranes, Corning #3412) in Medium RK1 at twice the density used for 
cultures on polystyrene.  The medium was changed initially after days 3 and 7 in culture, 
and daily, thereafter.   Cell surface biotinylation studies were conducted after 10-12 days. 
 
     To conduct cell surface biotinylation studies, the medium was changed in transwell 
cultures. Two hrs later, the monolayers were incubated for 30 minutes in the presence or 
absence of effector molecule (PG).  The monolayers were then placed on ice, washed, 
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first with ice-cold DME/F12 and then twice with PBS supplemented with 0.1 mM CaCl2 
and 1.0 mM MgCl2 (PBS-CaMg).  The cultures were subsequently incubated at 4o C for 
20 min. with NHS-ss-biotin (0.5 mg/ml) in biotinylation buffer (10 mM triethanolamine, 
pH 9.0, 2 mM CaCl2 and 150 mM NaCl), with gentle horizontal motion. This was 
followed by a second 20 min incubation in biotinylation buffer,  2 washes  with ice-cold 
PBS-Ca-Mg containing 100 mM glycine, and a final 20 min incubation at 4o C in PBS-
Ca-Mg containing 100 mM glycine.  The monolayers were then quickly washed with 
PBS-Ca-Mg. The filters were transferred to 35 mm dishes and the monolayers solubilized 
in 1 ml of lysis buffer (1% Triton X-100, 150 mM NaCl, 5 mM EDTA, 50 mM Tris, pH 
7.5, for 1 hr at 4 o C.  Cell lysates were removed from the filters with rubber policeman, 
and centrifuged at 14, 000 x g for 10 min at 4 o C.  
 
     Aliquots of the cell lysates (100-250 µg of protein) were used for the purification of 
biotinylated cell surface proteins, and protein determinations (Bradford method).  Cell 
lysates were incubated overnight with streptavidin sepharose beads. , The beads were 
washed 3 times with lysis buffer, twice with a high salt wash buffer ((lysis buffer 
containing 0.1% Triton X-100\ and 500 mM NaCl), and once with 10 mM Tris, pH 7.5.  
Proteins were eluted by heating 5 min at 100o C in SDS-PAGE sample buffer. 
 
Western Analysis 
     Na,K-ATPase in cell lysates was subjected to a Western analysis.  Samples of the 
streptavidin precipitates, and whole cell lysates (equalized with regards to protein by the 
Bradford method) were separated by electrophoresis through 7.5% SDS/polyacrylamide 
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gels, along with parallel samples of purified dog Na,K-ATPase and molecular weight 
markers. The proteins in the gel were transferred to nitrocellulose using a Trans-Blot 
Apparatus (Bio-Rad).  Nitrocellulose blots were blocked for 1 hr in Tris-buffered saline 
(TBS) containing 0.1% (v/v) Tween 20 (TTBS), followed by a 2 hr incubation in TTBS 
containing primary antibody (either an anti-Na,K-ATPase α or β subunit monoclonal 
antibody).  The blots were washed (5x with TTBS, 5 min/wash), and then incubated 45 
min with a secondary antibody  (goat anti-mouse horse radish peroxidase conjugate) 
After washing (6 x with TTBS, 15 min/wash).  Bands were visualized following a 5 min 
incubation in Immun-Star HRP Luminol/Enhancer by exposure to Bio Max MS2 Film. 
Na,K-ATPase α and β subunits were identified by their comigration with purified dog 
Na,K-ATPase and molecular weight. 
 
     As controls for equal loading, blots of biotinylated proteins were subsequently 
incubated 1 hr with mouse anti-biotin-alkaline phosphatase conjugate.  Bands were 
visualized by incubation in a reaction mixture containing 0.33 mg/ml nitroblue 
tetrazolium (NBT) and 0.17 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in 0.1 
M NaCl and 0.05 N MgCl2. The X-Ray films and blots were scanned with a Bio-Rad 
Scanning Densitometer, and the relative intensity of bands was quantitated using the 
Quantity One Program. 
 
Na,K-ATPase Assays in Vesicle Preparations 
The Na,K-ATPase activity in cell lysates was measured by the method of Forbush (25) as 
previously described by Taub et al. (67).  To summarize, primary RPT monolayers in 100 
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mm dishes were washed twice with sonication buffer (140 mM NaCl, 10 mM KCl, 10 
mM HEPES, pH7.4) and removed with a rubber policeman.  The cells were disrupted by 
sonication at 4 o C using three 5 second blasts.  The sonicated material was diluted five 
fold into preincubation buffer (10 mg/ml BSA, 2 mM EDTA, 25 mM HEPES, pH 7.0 and 
0.6 mg/ml SDS), and incubated 10 minutes at 23 o C.  The samples were then diluted 
fivefold using 3 mg/ml BSA in 25 mM HEPES, pH 7.0 (to reduce the SDS 
concentration), and maintained at 4 o C. Aliquots of this diluted material were added to 
assay mixture containing 120 mM NaCl, 25 mM KCl, 4 mM Na2ATP, 4 mM MgCl2, 1 
mM EDTA and 60 mM Tris-HCl, pH 7.5, and incubated 10 min at 37 o C.  
Determinations were in triplicate, both in the absence and in the presence of 1 mM 
ouabain.  The inorganic phosphate released from ATP was assayed using a modification 
of the Baginski method (5) (25).  In each cell culture condition, the specific Na,K-
ATPase activity was determined by calculating the difference in inorganic phosphate 
released in the presence and absence of 1 mM ouabain.  Determinations were 
standardized with respect to protein content by the Bradford method (10). 
 
86Rb+ Uptake Studies 
     To study chronic effects of PGE1, Rubidium (Rb+) uptake studies were conducted with 
confluent monolayers of primary RPT cells on 35 mm dishes, as previously described for 
MDCK cells (67).   To summarize, primary RPT cells were grown to confluence in 
Medium RKT.  The cultures were then maintained in experimental medium (DME/F12 
supplemented with 5 µg/ml insulin 5 µg/ml transferrin, and other appropriate 
supplements).  The medium was changed on a daily basis.  On the day of the uptake 
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experiment, the medium was once again changed, preincubating cells in either the 
presence or absence of 1 mM ouabain for 4 hours at 37o C in a 5% CO2/95% air 
humidified environment.  Immediately prior to the uptake period, the monolayers were 
washed twice at 23 o C with 2 ml of uptake buffer (10 mM Tris, pH 7.4, and 140 mM 
NaCl).  The monolayers were then incubated for 5 minutes at 23o C in uptake buffer 
containing 1 mM RbCl, and 6 µCi/ml 86Rb+.  Ouabain (1 mM) was also present in the 
uptake buffer of cultures that had been preincubated with ouabain.  At the end of the 
uptake period, the cultures were rapidly washed three times with ice-cold wash buffer (10 
mM Tris, pH 7.4, and 100 mM MgCl2), and lysed in 0.2 N NaOH. The cell lysates were 
neutralized with HCl. One half of the cell lysate was used for scintillation counting and 
the remainder was used for protein determinations, following the Bradford Method (10). 
The  labeled Rb+ uptake was determined in each of the cultures using a scintillation 
counter. The quantity of Rb+ uptake in nmoles was determined from the determination of 
the specific activity of the labeled uptake buffer. Each Rb+ uptake determination was 
standardized with regards to protein.  All uptake determinations were in triplicate and 
corrected for zero time uptake.   Values are averages +/- SEM. 
 
To study acute affects of PGE1 on Na,K-ATPase activity, ouabain-sensitive 86Rb+ uptake 
was determined by a modification of the method of Feraille et al. (20) . To summarize, 
monolayers of primary RPTs were washed twice with K+ free DME/F12  buffered with 
20 mM HEPES, pH 7.4, but lacking bicarbonate.  The cells were then preincubated for 30  
minutes at 23o C in the same medium supplemented with 5 µg/ml insulin, 5 µg/ml 
transferring and 1 µM indomethacin, in either the presence or absence of 1 mM ouabain. 
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Subsequently, agonists were added, followed by a second 30 min incubation period. 
86RbCl was then added to each culture ( 6 µCi/dish). After a 15 minute incubation, the 
uptake was stopped by cooling on ice, removal of the culture medium, and 3 washes with 
ice-cold wash buffer (150 mM choline chloride, 1.2 mM MgSO4, 1.2  mM CaCl2, 2 mM 
BaCl2 and 5 mM HEPES, pH 7.4).  The cultures were lysed in 1% (wt/vol) Na+ 
deoxycholate.  Radioactivity in the lysate was measured in a scintillation counter, and 
protein by the Bradford method, as described above. All uptake determinations were 
conducted in triplicate, and corrected for zero time uptake.  To determine the ouabain-
sensitive component of Rb+ uptake in each condition, ouabain-insensitive Rb+ uptake was 
subtracted from total Rb+ uptake (in the absence of ouabain)  Values are averages +/- 
SEM. 
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Results 
 
Effects of PGs and cAMP on ATP1B1 Gene Transcription 
     In order to determine whether expression of the Na,K-ATPase β1 subunit gene 
(ATP1B1) is regulated by PGs in primary RPT cells, transient transfection studies were 
conducted with  pHß1-1141 Luc (22).   Fig. 1A shows stimulatory effects of  an 18 hr 
incubation with  either 1.4 µM PGE1 (5.1 +/- 0.5 fold) or 1 mM 8Br-cAMP (4.7 +/- 0.8 
fold) on luciferase gene expression.   Fig. 1B compares the effects of 0.14 µM PGE1, 
PGE2  and PGF2α following an 18 hr incubation.   The results indicate that both PGE1 and 
PGE2 were stimulatory to an equivalent extent (5.1 +/- 0.5 fold, and 6.9 +/- 1.7 fold, 
respectively). The stimulatory effects of PGE1 and PGE2 were significantly higher than 
the effect of PGF2α (3.0 +/- 0.2 fold).   These results are consistent with the involvement 
of EP receptors (which have a high affinity for PGE1 and PGE2), rather than FP receptors.  
The concentration dependence of the PGE2 effect was then examined, because PGE2 is 
the major PG synthesized in the kidney (9).  Fig 1C shows a maximal effect of PGE2 was 
obtained at 0.28 µM.  
 
Expression of EP Receptors in Primary RPT Cell Cultures 
     PGE1 and PGE2  stimulate ATP1B1 transcription  through a number of signaling 
pathways, which are initiated by the interaction of PGE1 and PGE2 with specific PGE 
receptors.   In the kidney, PGE1 and PGE2 interact with 4 different classes of G Protein 
Coupled EP Receptors (40) including EP2 and EP4, which are coupled to adenylate 
cyclase (AC) via Gs,  EP3, which is coupled to AC via Gi, and  EP1, which is coupled to 
Phospholipase C (PLC) via Gq.    Although all 4 EP receptors are present in the kidney 
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(11), the EP receptors present in the RPT have not clearly been defined.  The receptors, 
which are responsible for mediating PGE1 and PGE2 action in the RPT (and thus the 
possible signaling pathways involved) had not yet been defined.  Thus, RealTime PCR 
was employed to quantitate the level of expression of the mRNAs for the 4 EP receptors 
in primary RPT cells and purified RPTs.    The relative level of expression of each 
mRNA was compared to that in the medulla, a previously studied tissue (13). 
 
Fig. 2A shows that a significant level of each of the 4 EP receptor mRNAs was present in 
primary RPTs as well as purified proximal tubules. While the level of EP2 and EP3 
mRNA was equivalent to that of purified proximal tubules (1.0 +/0.04 and 1.04 +/- 0.22 
fold, respectively), the level of EP1 and EP4 mRNA was significantly lower (0.71+/- 
0.03 and 0.30 +/- 0.03 fold of the level in purified proximal tubules, respectively). In both 
primary RPTs and purified RPTs, the level of all  EP receptors was significantly lower 
than in the medulla, including in particular EP3 (Fig. 2B).  
 
Involvement of Gs Coupled EP Receptors 
In order to determine whether Gs coupled EP2 and EP4 receptors mediate the PGE 
response,  transient transfection studies were conducted using EP2 and EP4 specific 
agonists and antagonists over a 4 hr incubation.  The EP2 specific  agonist butaprost, as 
well as the EP2 and EP4 specific agonists  PGE1-OH and 16,16 dimethyl PGE2 were 
used.  As shown in Fig. 3A, both butaprost (0.1 µM) and PGE1-OH (0.5 µM) were 
stimulatory. Similarly, as shown in Fig. 3B, 16,16 dimethyl PGE2 (0.25 µM)(16, 17), 
caused a  6.1 +/- 0.6 fold stimulation (equivalent to that of  PGE1 and PGE2).  While the 
results with butaprost clearly indicate that EP2 receptors can mediate a stimulatory effect 
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on ATP1B1 transcription, the results with PGE2-OH and 16,16-dimethyl PGE2 could also 
be explained by EP4 receptor mediated events.  
 
 In order to determine whether EP4 receptors are indeed involved, 2 highly specific EP4 
antagonists, L161,982 and MF191, were employed at concentrations known to 
specifically inhibit PGE action via EP4 receptors (44) (42).  Fig. 3C shows that 0.25 µM 
L161,982 and 0.01 µM MF191 both inhibit the PGE1 stimulation  by 81 +/- 3 % and 83 
+/- 7%, respectively.  
 
In order to further evaluate whether Gs coupled EP2 and EP4 receptors are involved, we 
examined the effects of PKI (a myristolyated PKA inhibitor) and the AC inhibitor 
SQ22536 on the PGE1 stimulation.  As shown in Fig. 3D, 10 µM PKI and 0.3 mM 
SQ22536 inhibited the PGE1 stimulation by 39 +/- 3%, and 48 +/- 0.5%, respectively.  
The stimulatory effect of 8BrcAMP  (shown in Fig. 1 above) is also consistent with these 
results. 
 
Involvement of Gq Coupled EP1 Receptors 
 In order to determine whether Gq coupled EP1 receptors are also involved, the effects of 
several EP1 specific agonists and antagonists were examined. Fig.  4A shows that the 
EP1 agonist 17-phenyl trinor PGE2 was significantly stimulatory at concentrations 
ranging from 5 µM (3.1 +/- 0.3 fold) to 20 µM (4.4 +/- 0.3 fold).   In contrast, two EP1 
receptor antagonists, SC51089 (1 µM) and AH6809 (1 µM) (16),  were significantly 
inhibitory to the PGE1  stimulation (Fig. 4B). Thus, these results suggest that both the 
activation of PLC and AC are involved in mediating the PGE stimulation. 
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Role of Ca2+ and PKC  
      Consequences of the activation of PLC include an increase in intracellular Ca 2+ and 
the activation of PKC.  Consistent with the involvement of PKC, is the observation 
(shown in Fig. 5A) that phorbol 12-myristate-13 acetate (TPA) was stimulatory between 
10-9 and 10-7 M.  A maximal effect of this PKC activator was obtained at 10 -9 M (3.2 +/- 
0.5 fold control). 
 
In order to determine whether the PGE1 stimulation depends upon the activation of PKC, 
the PKC inhibitor GÖ 6976 was employed.  As shown in Fig. 5B, 40 nM GÖ 6976 reduced 
the PGE1 stimulation by 71 +/- 4%   (such that a 1.6 +/- 0.2 fold stimulation was obtained 
with + GÖ 6976 and PGE1, as compared with 4.8 +/- 0.5 fold with PGE1 alone).  Fig. 5B 
shows that 40 nM GÖ 6976 similarly reduced the stimulatory effect of 10 -9 M TPA.  A 
1.8 +/- 0.2 fold stimulation was obtained with TPA and GÖ 6976, as compared with a 2.8 
+/- 0.3 fold stimulation with TPA and a 1.5 +/- 0.1 fold stimulation with GÖ 6976.  GÖ 
6976 (at 40 nM) inhibits PKC α, PKC ß1 and PKC µ. Ro-32-0432, which inhibits the 
PKC α and PKC ß1 at 25 nM, similarly reduced the TPA stimulation (Fig. 5C). Thus 
these results support the hypothesis that the PGE1 stimulation of ATP1B1 gene 
transcription is dependent upon the activation of PKC α and/or PKC ß1, a consequence 
of signaling through EP1 receptors.  However because the inhibition produced by the 
PKC inhibitors was only partial, the results are also consistent with the involvement of 
other classes of EP receptors.  
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EP1 receptor activation has been observed to cause an increase in intracellular Ca2+, 
which contributes to the activation of PKC (17).  In order to determine whether such an 
increase in intracellular Ca2+ is sufficient to affect ATP1B1 gene transcription, the effects 
of a) ionomycin, a Ca2+ ionophore which increases cytoplasmic Ca 2+, b) BAPTA-AM, a 
Ca 2+ chelator which reduces cytoplasmic Ca 2+, and c) TMB-8 , an agent which inhibits 
Ca2+ efflux from intracellular stores (9),  were examined.  Fig. 6A shows that 1 µM 
ionomycin causes a 2.3 +/- 0.5 fold stimulation.  The stimulatory effect of ionomycin was 
reduced in the presence of 2.5 x 10 -5 M BAPTA-AM (to 1.4 +/- 0.2 fold of Control).  In 
contrast, as shown in Fig. 6B, 10–4 M TMB-8 was stimulatory after a 19 hr. incubation.   
Thus, the effects of agents that perturb intracellular Ca 2+ on ATP1B1 transcription 
depend upon their specific underlying mechanisms of action.  
 
Actions of Endogenously Produced Renal Effector Molecules.  
      The RPT produces PGs and other AA metabolites in response to changes in dietary 
Na+ (33, 34).  Thus, the effect of AA on transcription was examined as a function of AA 
concentration.  An 18 hr incubation period was employed, so as to allow  for substantial 
metabolism of AA.  Fig. 7A shows that AA caused a significant stimulation between 10–
10 to 10–7 M, with a maximal effect at 10-9 M.   In order to determine whether the 
stimulatory effect of AA depends upon its metabolism by cyclooxygenase (COX), the 
COX inhibitor indomethacin was employed.  Fig. 7B shows that 10-6 M indomethacin 
reduced the stimulatory effect of 10-9 M AA by 83 +/- 2% (such that only a 2.7 +/- 0.2 
fold stimulation was obtained in the presence of indomethacin and AA, as compared with 
a 12 +/- 2 fold stimulation obtained with AA alone).  Thus, the majority of the 
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stimulatory effect obtained by the addition of AA could be attributed to AA metabolites 
generated by COX.   
 
 Na,K-ATPase in the RPT is regulated by 20-Hydroxyeicosatetraenoic acid (20-HETE), 
and 5,6-Epoxyeicosatrienoic acid (5,6 EET) (34).  Fig. 8A shows that a 3.4 fold 
stimulation was obtained in response to 10–6 M 20-HETE, an AA metabolite generated by 
cytochrome P-450 ω-hydroxylase.  Fig. 8B shows that a 2.2 fold inhibition was obtained 
in response to 10–6 M 5,6 EET, an AA metabolite generated by cytochrome P450 
epoxygenase. Thus, at least 3 different pathways of AA metabolism affect ATP1B1 gene 
transcription in the RPT. 
 
The kidney produces catecholamines in response to changes in dietary Na+, including 
norepinephrine and dopamine (3) [27].  In order to determine whether norepinephrine and 
dopamine affect ATP1B1 transcription, transient transfection studies were conducted 
using both 3 and 8 day old cultures.  Figure 9A shows that 10 -6 M norepinephrine was 
stimulatory in both 3 and 8 day old cultures (causing a 2.2 +/- 0.3, and a 2.1 +/- 0.4 fold 
stimulation, respectively).   This observation is consistent with the observed stimulatory 
effect of norepinephrine on Na,K-ATPase in the RPT. Figure 9A also shows a 
stimulatory effect of 10 µM dopamine (1.8 +/- 0.1 fold in both day 3 and 8 in culture).  
This latter observation contrasts with the acute inhibitory effect of dopamine on renal 
proximal tubule Na,K-ATPase, which results in natriuresis. 
 
 
Chronic and Acute Effects of PGs on the Na,K-ATPase 
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     In order to determine whether PGs affect the level of Na,K-ATPase, primary RPT 
cells were incubated either in the presence or absence of 1.4 µM  PGE1 for 4 days. 
Indomethacin was present so as to prevent endogenous PG production.   Fig. 10 A and B 
show that the level of the α subunit increased by 4.2 +/- 0.6 fold, while the level of 
glycosylated and unglycosylated ß subunit increased by 3.3 +/- 0.5 and 4.6 +/- 1.0 fold, 
respectively.  Fig. 10 C shows that in parallel cultures, the level of α and β subunit 
mRNA had increased by 2.2 +/- 0.34 fold and 5.1 +/- 0.4 fold, respectively.  
 
     In order to determine whether the PGE-mediated increase in the level of Na,K-ATPase 
is associated with an increase in Na,K-ATPase activity, Rb+ uptake studies were 
conducted.  Primary RPT cell cultures were first incubated for 4 days either in medium 
containing 250 ng/ml PGE1., or with no further supplement (Control), followed by Rb+ 
uptake studies.   As shown in Fig. 10D, the initial rate of Rb+ uptake increased by 1.8 +/- 
.2 fold in the presence of PGE1. Fig. 10D also shows that this observed increase in the 
Rb+ uptake rate could be explained by an increase in the ouabain-sensitive component of 
Rb+ uptake (2.0 +/- 0.3 fold relative to the Control).   
 
     Na,K-ATPase activity was also determined in membrane vesicle preparations. In these 
studies cultures were treated 4 days with 125 ng/ml PGE1 and 0.125 mM 
isobutylmethylxanthine (IBMX), a cAMP phosphodiesterase inhibitor, to further increase 
intracellular cAMP levels. Fig. 10E shows that the Na,K-ATPase activity in membrane 
preparations derived from cultures treated with PGE1 and IBMX (30.7 +/- 0.5 µmoles/mg 
protein/hr) was significantly higher than in membrane preparations obtained from control 
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cultures maintained in either presence or the absence of IBMX (1.7 +/- 0.03, and  2.4 +/- 
0.04 fold increase, respectively). Thus, the observed increase in the rate of Rb+ uptake in 
PGE1 treated cultures could indeed be explained by an increase in Na,K-ATPase activity. 
 
     Acute incubations with effector molecules has been observed to change the level of 
basolateral Na,K-ATPase without affecting  the overall cellular level of Na,K-ATPase 
(23).  To study such acute affects, primary RPT cells were cultured on transwell 
membranes. Following a 30 min incubation with either a) PGE1, b) butaprost or c) 17-
phenyltrinor PGE2, basolateral proteins were biotinylated, and purified using Streptavidin 
Sepharose. Fig. 11 shows the results of a Western analysis of the biotinylated proteins.  
The level of the α subunit increased by 5.4 fold in cultures incubated with 1.4  µM PGE1 
, 3.9 fold in cultures incubated with the EP2 agonist butaprost, and 2.6 fold in cultures 
incubated with the EP1 agonist 17-phenyltrinor PGE2.   
 
     In order to determine whether the acute affects of PGE1 on basolateral Na,K-ATPase 
results in a change in Na,K-ATPase activity, 86Rb+ uptake studies were conducted.  Fig. 
11B shows that following a 30 min incubation with 1.4 µM PGE1, ouabain-sensitive Rb+ 
uptake increased 43 +/- 2%. A similar increase was observed with 0.125 mM IBMX.  
However, in the presence of both 1.4 µM PGE1 and 0.125 mM IBMX the rate of ouabain-
sensitive Rb+ uptake decreased to 24 +/- 16% of the Control level.  These results indicate 
that PGE1  does indeed cause an acute increase in Na,K-ATPase activity in primary RPTs 
in addition to chronic regulation at the transcriptional level.  However the observed 
decrease in ouabain-sensitive Rb+ uptake in the presence of IBMX as well as PGE1, 
 25 
suggests that acute regulation in response to PGE1 is dependent upon the  cells’ cAMP 
status. 
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Discussion 
 
     PGE2 is the major metabolite of COX in all sections of the nephron, including the RPT 
(9). PGs produced by RPT, as with all the nephron segments, act as autocrine factors, that 
regulate transport and metabolism in the same cells that produce these autocoids (13).  In 
this report the effects of endogenous PGs have been studied in a primary proximal tubule  
(RPT) cell culture system that produces PGs in vitro in a manner similar to intact RPTs 
which are present in vivo (1) . RPTs in vivo produce PGs, of which > 90% is PGE2, 
followed by PGF2α, and 6-keto-PGF1 α (9).   Similarly, PGE2 is produced to the largest 
extent by the primary RPT cells (5 ng/mg protein/hr), followed by PGF2α (1 ng/hr)α and 
6-keto-PGF1α (0.6 ng/hr) (1).  Thus, the primary cultures produce enough PGE2 within 5 
hrs to stimulate Na,K-ATPase β subunit gene expression 7 fold, unlike the case with 
PGF2α.  Moreover PGE2 has been observed to play a significant role in regulating renal 
Na+ reabsorption in the kidney (12) (9, 32, 59).    PGE1 has been found to act in a 
virtually identical manner to PGE2, interacting with the same set of receptors (17).  For 
this reason, the effects of PGE1 as well as PGE2 have been studied. 
 
     Previously, G Protein Coupled Receptors (GPCRs) have been identified in the kidney, 
which are specific for PGs (12).  PGE1 and PGE2 in particular interact with a specific 
subset of these GPCRs, the EP receptors (12).  Four subtypes of EP receptors have been 
identified (11).   EP1 receptors are primarily in the collecting duct, where they inhibit Na+ 
and water reabsorption via a Ca2+ coupled mechanism.  Despite the relatively low levels 
of renal EP2 receptors, EP2 receptor knockout mice have salt-sensitive hypertension.  In 
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contrast, EP3 receptor knockout mice are relatively unaffected in their renal 
concentrating ability. This finding is surprising in light of the proposed involvement of 
EP3 receptors in mediating the inhibitory effects of PGs on vasopressin stimulated salt 
and water absorption.  Gs-coupled EP4 receptors are expressed primarily in the 
glomerulus (12).  In addition, EP4 receptors have been proposed to be present at lower 
levels in individual nephron segments, including the proximal tubule (12).   
 
     Investigations with intact animals indicate that PGs have profound affects on renal 
function.  However,  subsequent to these studies, experiments were conducted with 
isolated perfused tubules, because a number of the observed effects on reabsorption in 
intact animals may be the indirect consequence of PG affects on renal blood flow (9, 24).   
However, only acute affects were studied with isolated perfused tubules, and precise 
molecular mechanisms still need to be defined.  In vitro cell culture systems are more 
amenable to the study of molecular mechanisms than other model systems. 
 
     Previously, we studied the chronic effects of PGs on the Na,K-ATPase in MDCK 
cells,   a model of  the distal tubule (65).  Our results indicate that PGE1 and PGE2 
stimulate the Na,K-ATPase activity in MDCK cells, which could be explained at least in 
part by transcriptional control (65) (67).  However, it was unclear whether PGs have 
similar affects on cells in other nephron segments.   Moreover, the physiologic 
significance of these studies was unclear, because the MDCK cell line may have changed 
during its establishment in culture.  
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     Thus, in this report we examine the effects of PGs on transcription of the ATP1B1 
gene in primary RPT cells, which have just been removed from the animal.  Four major 
results obtained from these studies include the observations that: 1) Both primary RPT 
cell cultures and purified RPTs express EP1, EP2, EP3 and EP4 receptors, albeit to a 
lower extent that in the medulla. 2)  Gq coupled EP1 receptors as well as Gs coupled EP2 
and EP4 receptors  mediate the stimulatory effects of PGE1 and PGE2 on ATP1B1 
transcription in primary RPTs.  These results are based upon the observed inhibitory 
effects of the EP1 antagonists SC51089 and AH6809, as well as the EP4 antagonists 
L161,982 and MF191.   In addition, stimulatory effects of the EP1 agonist 17-phenyl 
trinor PGE2, the EP2 agonist butaprost, and the EP2/EP4 agonists PGE1-OH and 16,16 
dimethyl PGE2.  3) Other renal effector molecules known to regulate transport in the RPT 
stimulate ATP1B1 transcription, including norepinephrine and dopamine.  4) Chronic 
treatments with PGE1 and PGE2 result in an increase in the levels of the mRNAs for the 
Na,K-ATPase, as well as in the total level of cellular Na,K-ATPase.  Acute treatments 
result in an increase the level of Na,K-ATPase in the basolateral membrane without an 
increase in the overall level of cellular Na,K-ATPase. Both chronic and acute treatment 
result in an increase in Na,K-ATPase activity. 
 
     The evidence that PGE1 and PGE2 affect primary RPTs via mechanisms similar to 
those reported previously in MDCK cells includes our results with the EP1 antagonists 
SC51089 and AH6809 (17, 37, 40) and the EP2/EP4 agonist 16,16 dimethyl PGE2(16). In 
addition, the involvement of Gs coupled EP2/EP4 receptors was indicated by the ability 
of PKAI to inhibit the PGE1 stimulation, as previously described in MDCK (65). Unlike 
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EP2 and EP4 receptors, Gq-coupled EP1 receptors are coupled to PLC.  A consequence 
of the activation of PLC (16)  is the generation of diacylglycerol and inositol 1,4,5 
trisphosphate, an elevation in intracellular Ca2+, and the activation of PKC.  The 
stimulatory effects of ionomycin and TMB-8 substantiated the involvement of 
intracellular Ca2+.  TMB-8 causes a decrease in cytoplasmic Ca 2+. However, at the same 
time TMB-8 (like ionomycin) increases the level of Ca2+ in intracellular stores, which 
could explain its stimulatory effects. The involvement of PKC was supported by the 
inhibitory effects of GÖ 6976 (27, 51) and Ro-32-0432 (8, 71), also as previously 
described in MDCK cells (65), a distal tubule model.  Thus, PGE1 and PGE2 apparently 
regulate ATP1B1 transcription by similar cAMP, as well as Ca2+ mediated mechanisms in 
primary RPT cells as well as MDCK cells. 
 
     A number of lines of evidence indicate that similar PGE-mediated effects on 
transcription of Na,K-ATPase also occur in the renal proximal tubule in vivo. PGE2 
infusion into the rat renal interstitium has been reported to enhance Na+ reabsorption by 
superficial proximal convoluted tubules (PCTs) (39).  PGE2 is produced in the kidney in 
response to low doses of Ang II (49), and thus has been proposed to elicit effects on Na+ 
reabsorption which are similar to those elicited by low doses of Ang II.  Included 
amongst the mechanisms by which Ang II increases Na+ reabsorption in the PCT is 
through its stimulatory effects on Na,K-ATPase (3).  Such stimulatory effects of Ang II 
on Na,K-ATPase in the RPT contribute to the Na+ retention that occurs in rats with 
experimental heart failure (68).  In contrast, the distal tubule exhibits decreased Na,K-
ATPase activity in this condition (68).  Thus, the PGE-mediated effects on transcription 
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of  Na,K-ATPase in the distal tubule are elicited under a distinct set  of physiologic 
conditions  in vivo.   
 
     In addition to its role as a mediator in Ang II action, PGE2 is also involved in 
reversing the inhibitory effects of PTH on solute reabsorption in the rabbit Proximal 
Straight Tubule (PST) (19).  Included amongst the effects of PTH on the RPT is the 
inhibition of the Na,K-ATPase  (38) as well as the Na+/Pi cotransport system (7) and the 
Na+/H+ antiport system (47).  Although effector molecules like PTH also regulate Na,K-
ATPase in the distal nephron, differences in mechanisms have been reported (55).  
 
      Our results indicate that the responses of primary RPTs and MDCK cells to PGE1 and 
PGE2 are mediated by signal transduction pathways that are similar, albeit not identical.  
The EP4 antagonists L161,982 and MF191 inhibited the stimulatory effect of PGE1 in 
primary RPT cells, unlike the case with MDCK cells (unpublished).  Similarly, Sauvant 
et al (56) obtained evidence for the involvement of EP4 receptors in mediating the 
stimulatory effects of PGE2 on basolateral organic anion transport in OK cells, another 
RPT  model system.  The investigations of Lopes et al. (43) provide additional evidence 
for a role of PGs in transport regulation in the RPT. The studies of these investigators 
indicate that the acute inhibitory effect of Ang-(1-7) on Na+-ATPase in the RPT is 
mediated by endogenous PGE2  (43),  Finally,   the investigations of Jensen et al. (35), 
indicate that phosphate transport by mouse proximal convoluted tubules is inhibited by 
PGE2. 
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     PGE2 has additional affects on transport in other nephron segments.  In the collecting 
duct, activation of EP1 by 17-phenyl-trinor PGE2 has been observed to cause inhibition 
of Na+ and water reabsorption, while activation of EP3 by MB-28767 had no effect (12) 
(11).  However EP3 receptors have been localized to the medullary Thick Ascending 
Limb (mTAL), where they may exert their effects, although EP2 receptor mRNA has 
been detected along the nephron , the cAMP mediated effects of PGE2 on transport in the 
CD are not mimicked by the EP2 agonist butaprost, and have instead been attributed to 
EP4 receptor activation (12). EP2 receptors have a clearly defined role as vasodialators, 
which may explain the hypertension which occurs in EP2 knockout mice (12). In 
contrast, EP4 receptors have been proposed to activate salt and water absorption along 
the nephron (11).   
 
 Because of these other affects of PGE2 in other regions of the nephron, it is important 
that our primary RPTs do indeed consist of a population of purified proximal tubule cells. 
.  Included amongst our previous results which support the contention that the primary 
RPTs consist of a highly enriched population of  differentiated proximal tubule cells, are 
our transport studies. The initial rate of p-AH uptake by basolateral membrane vesicles 
obtained from the primary cultures and purified rabbit kidney proximal tubules was 
equivalent (72). Similarly, the initial rate of 14C- α-methyl-D-glucopyranoside (α MG) 
uptake in the primary RPT cell cultures is comparable to that observed in rabbit kidney 
cortical slices (6, 14). The kinetic properties of transport by the Na+/glucose cotransport 
system (SGLT1), and the Na+/Pi cotransport system (Npt2) similarly resemble those 
defined for SGLT1, and Npt2, respectively, in LLC-PK1 cells cultures (52, 70). The 
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observation that the level of SGLT1 remained constant after passaging (64), and the 
expansion of clonal isolates of RPTs, following their immortalization with SV40 early 
region genes (66), also supports the contention that the primary cultures consist of a 
highly purified  population of proximal tubule cells. 
 
    In addition, our results with apical membrane proteins indicate that the primary RPTs 
are highly enriched with proximal tubule cells. The primary RPTs express γ-GT , alkaline 
phosphates and leucine aminopeptidase.  Over 90% of the primary RPTs express  γ-GT, 
as do the purified proximal tubule preparations, In addition, all 5 of our immortalized 
RPT clones, like the primary RPTs, express  these apical membrane proteins (14). 
 
     Finally, the hormone responsiveness of  the primary cultures is consistent with the 
contention that these cultures consist of a highly purified population of RPTs.  The 
primary cultures possess PTH-sensitive adenylate cyclase activity, while lacking 
responsiveness to arginine vasopressin and calcitonin. In contrast, the renal cortex 
exhibits a significant response to arginine vasopressin and calcitonin due to a small 
proportion of cells derived from the distal tubule and loop of Henle (46).  
 
     The Na,K-ATPase consists of an α subunit with catalytic activity, as well as a β 
subunit required for the integration of Na,K-ATPase into the plasma membrane (26).  
The β subunit has been proposed to be a limiting factor in the formation of intact α/ß 
heterodimers (excess α subunits being rapidly degraded) (26).   Indeed over-expression 
of the β1 subunit has been observed to result in a corresponding increase in the 
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expression of endogenous α in a number of cell systems including Xenopus Laevis 
oocytes (58), and Moloney Sarcoma Virus - transformed MDCK cells (53).  However, 
recently, Laughery et al. (41) have reported that over-expression of flag tagged β1 in 
MDCK cells does not lead to a significant change in expression of either endogenous α 
or β1 Na,K-ATPase subunits. In this report, the observed increase in transcription of the 
β1 subunit is associated with an increase in the level of both the α and β subunits in the 
primary RPT cell cultures.  In addition, α as well as β subunit mRNA levels increase in 
primary RPTs in response to PGE.  Thus, additional studies are necessary to evaluate 
whether an increase in α subunit gene transcription also plays a role in regulating the 
level of Na,K-ATPase in the proximal tubule.  
 
     Our results indicate that β subunit gene expression increases to a large extent that α 
subunit gene expression both in primary RPT cells and in MDCK cells.  The results that 
we obtained by means of RealTime PCR indicate that in primary RPTs treated with 0.7 
µM PGE1, the level of β subunit mRNA increased to a 2 fold higher extent than the level 
of α subunit mRNA.  We obtained a similar result previously through a Northern analysis 
of 8BrcAMP treated primary RPTs (30).   A consequence of the increased expression of 
the Na,K-ATPase α and β subunit mRNA levels in PGE treated primary RPTs is an 
increase in the level of the Na,K-ATPase, as well as in Na,K-ATPase activity.  However, 
the results of our Western analysis of Na,K-ATPase α and β subunits indicates that  the 
observed  increase in unglycosylated β subunit  in PGE1 treated primary RPTs was only 
slightly higher (10%) than the increase in α subunit.  The increase in the level of 
glycosylated β subunit did not differ significantly than the observed increase in the α 
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subunit.  Similarly, in MDCK cells we previously reported a 7 fold increase in β subunit 
mRNA and a 2 fold increase in α subunit mRNA mediated by PGE1 concentrations (65). 
Nevertheless, the increase in the α subunit level did not differ significantly from the level 
of the β subunit in MDCK cells. However, consistent with β subunit being limiting are 
our preliminary results with MDCK cells that indicate a knockdown of the β subunit with 
β subunit siRNA results in a reduction in the α subunit level. 
 
     PGs are modulators of renal microvascular hemodynamics and renin release as well as 
tubular salt and water reabsorption (11).  PG biosynthesis by cyclooxygenase (COX) 
occurs in all sections of the nephron, including the RPT (9, 11).  Thus, the stimulatory 
effect of AA on transcription by pHß1-1141 Luc can very likely be attributed to autocrine 
effects of endogenously produced AA metabolites, including PGE2. Indeed, the 
stimulatory effect of PGE2 was inhibited over 80% by the COX inhibitor indomethacin. 
However, our results indicate that AA metabolites, including metabolites generated by 
cytochrome P450 (such as 20-HETE) also contribute to the stimulatory effect of AA (60).   
 
     In addition, our results indicate that several other intra-renal factors, norepinephrine 
and dopamine, regulate ATP1B1  transcription in primary RPT cells. Previously, both 
norepinephrine and epinephrine  were observed to cause an acute increase in renal Na,K-
ATPase activity in the RPT, characterized by a redistribution of Na,K-ATPase from the 
cytosolic to basolateral compartment (3).   Norepinephrine and epinephrine are produced 
in two distinct locales, in response to distinct stimuli.  While epinephrine is produced by 
the adrenal gland in response to stress, norepinephrine is produced by renal nerves when 
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dietary Na+ is low.  When dietary Na+ is reduced for a lengthy time, chronic regulatory 
mechanisms also come into play (2).    The consequence is an increase in transcription of 
the ATP1B1 gene in response to norepinephrine, as we have observed here.  
 
     Unlike norepinephrine, dopamine, is produced in the RPT from L-DOPA by an 
aromatic L-amino acid decarboxylase (4). Following the biosynthesis of dopamine in the 
RPT (presumably when dietary salt intake increases), dopamine acts via dopamine D1-
like receptors so as to acutely inhibit the RPT Na,K-ATPase.  In contrast, dopamine has a 
chronic stimulatory effect on ATP1B1 gene transcription in primary RPTs.  This 
stimulation may possibly be the consequence of signaling through dopamine D2-like 
receptors.  Indeed, Narkar et al (48) have reported a dopamine D2-like receptor mediated 
stimulation of Na,K-ATPase in rat RPTs treated with the D2 agonist bromocriptine.   
Similarly, a stimulatory effect of dopamine on Na,K-ATPase has been observed in  lung 
alveolar epithelial cells, and has been attributed to a stimulation of ATP1B1 gene  
transcription (28). 
 
     Similarly, chronic effects of PGs on Na,K-ATPase on primary RPTs  differ from 
previously reported acute affects in collecting duct cells, both in vitro and in vivo (15).  
In primary RPTs a stimulatory effect of PGE1 and PGE2 was observed following an acute 
as well as a chronic treatment.  These results may accurately reflect long-term as well as 
short-term regulation in the RPT in response to increases in the levels of PGs, and 
changes in Na+ balance (59).  During short-term fluctuations in Na+ balance, the 
tubulogomerular feedback mechanism stabilizes renal Na+ secretion (59).  Long-term 
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changes in Na+ balance are characterized by an altered rate of renin secretion, as well as 
changes in the level of Ang II, and COX 2 in the macula densa (59).  Increases in 
ATP1B1 gene transcription in the RPT cells may be one of the consequences of such 
changes in renal cortical COX 2 activity, in addition to other long-term physiologic 
changes.  
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Figure Legends 
Figure 1.  Effects of Prostaglandins on Transcription.  Primary RPT cells were 
transfected with pH ß1-1141 Luc and pSVßgal, as described in Materials and Methods.  
A) Effect of PGE1 and 8Br-cAMP.  Transfected primary RPT cells were incubated for 18 
hr either in DME/F12 supplemented with 5 µg/ml insulin and 5 µg/ml transferrin 
(Control), Control Medium with 1.4 µM PGE1 or Control Medium with 1 mM 8Br-
cAMP. B) Effect of 1.4 µM PGE1, PGE2 and PGF2α. Primary RPT cells were incubated 
for 18 hr either in Control medium, or in Control medium further supplemented with 0.14 
µM of either PGE1, PGE2 or PGF2α.  C) The effect of PGE2 Concentration.  Transfected 
primary RPT cells were incubated for 18 hrs with PGE2 at concentrations ranging from 0 
to 1.4 µM. At the end of the 18 hr incubation the cultures were lysed.  After the luciferase 
and ß galactosidase activity was determined in each cell lysates, the luciferase activity 
was standardized for transfection efficiency. In each condition the fold stimulation of 
luciferase activity was compared with the Control.  Values are averages +/- SEM of 
quadruplicate determinations.  * p< 0.05 vs. Control.  
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Figure 2. Expression of EP Receptors in RPT Cells. A. The Expression of EP1, EP2, EP3 
and EP4 Receptor mRNA in Primary RPT cells was compared to the levels in purified 
RPTs as described in Materials and Methods.  B. The Expression of EP1, EP2, EP3 and 
EP4 Receptor mRNA in primary RPT cells and purified RPTs was compared to the levels 
in the medulla.  Values are averages +/- SEM of triplicate determinations. 
 
Figure 3.  Effects of EP2 and EP4 Receptor Agonists and Antagonists.  A) Effects of 
butaprost and PGE1-OH.  B) Effects of 0.28 µM PGE1, PGE2,  and 16-16 dimethyl PGE2 
C) Effect of L161, 982 and MF191. D) Effect of PKI and SQ22536.  Values are the 
averages +/- SEM of quadruplicate determinations.  * p<0.05 
 
Figure 4.  Effects of EP1 Agonists and Antagonists.  A. Effect of 17-phenyltrinor PGE2.  
B.  Effect of 1 µM AH 6809 and 1 µM SC51089, either in the presence of the absence of 
1.4 µM PGE1.   * p<0.05 vs Control. 
 
Figure 5. Effects of TPA and PKC Inhibitors. A) Effect of TPA. Primary RPT cell 
cultures were incubated for 4 hrs with either 0, 10–9 M, 10-8 M or 10-7 M TPA. B) Effect 
of Gö 6976 on the PGE1 Stimulation. Primary RPT cell cultures were incubated for 4 hrs 
with either 10-9 M TPA, 1.4 µM PGE1, 1.4 µM PGE1 + Gö 6976, 10–9 M TPA + 40 nM 
Gö 6976, or no further supplement (Control). C) Effect of Ro-32-0432 on the PGE1 
Stimulation.  Primary RPT cells were incubated for 4 hrs with either 1.4 µM PGE1, 10–9 
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M TPA, 25 nM Ro-32-0432-1 + 1.4 µM PGE1, 25 nM Ro-32-0432-1 + 10–9 M TPA, 25 
nM Ro-32-0432-1, or no further supplement (Control).  Differences were statistically 
significant when p< 0.05 (*). 
 
Figure 6. Effect of Agents that Modulate Ca2+ Metabolism.  Primary RPT cell cultures 
were transiently transfected as described in Materials and Methods. Subsequently, effects 
of agents that modulate Ca2+ metabolism were examined. A) Effect of Ionomycin and 
BAPTA-AM.  Primary RPT cell cultures were incubated for 4 hrs either with DME/F12 
supplemented with 5 µg/ml insulin and 5 µg/ml transferrin (Control), or in the Control 
condition further supplemented with either 1 µM ionomycin, 2.5 x 10–5 M BAPTA-AM 
individually, or ionomycin and BAPTA in combination.  B) Effects of TMB-8 and 
Ionomycin. Primary RPT cell cultures were incubated for 19 hrs either with 10-6 M TMB-
8 or 1 µM ionomycin.  Values were significantly different from the control when p< 0.05 
(*). 
 
Figure 7.  Effects of Arachidonic Acid and its Metabolites. A) Effect of AA 
concentration. Primary RPT cells were transiently transfected with pHß1-1141 Luc and 
pSVßgal.  Subsequently, the transiently transfected primary RPT cells were incubated for 
18 hr with AA at concentrations ranging from 10–10 to 10–7 M. B) Effect of Indomethacin. 
Primary RPT cells were preincubated for 30 min. either in the presence or the absence of 
10-6 M indomethacin.  Subsequently, the cultures were incubated for 18 hr with either 10–
9 M AA, 10-9 M AA with 10 –6 M indomethacin, 10–6 M indomethacin alone, 1.4 µM 
PGE2 or with no further supplement (Control). Cultures were lysed and luciferase 
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determinations made as described in the legend to Figure 1. Differences were statistically 
significant when p<0.05 (*). 
 
Figure 8. Effect of 20-HETE and 5,6-EET.  A) Effect of 20-HETE. Primary RPT cells 
were incubated for 4 hrs with either 1 µM 20-HETE, 1.4 µM PGE1, 1 mM 8Br-cAMP, or 
Control (no further supplement).  B) Effect of 5,6 Epoxyeicosatrienoic Acid (5,6-EET). 
Primary RPT cells were treated with either 1 µM 5,6 EET, 0.070 µM PGE1 or 0.70 µM 
PGE1 for 4 hr.  Values were significantly higher than the Control when  * p< 0.05 (*), or 
lower than the control when ** p < 0.05  vs. AA. 
 
Figure 9.  Effect of Norepinephrine and Dopamine on Transcription. Primary RPT cells 
were transiently transfected with pHß1-1141 Luc and pSVßgal, after either 3 or 8 days in 
culture, as described in Materials and Methods. Subsequently, the primary cultures were 
incubated for 4 hrs in Control Medium supplemented with 5 µg/ml insulin, 5 µg/ml 
transferrin, 10-6 M indomethacin, and either 1) 10-6 M norepinephrine, 2)  10 µM 
dopamine, or 3) no further supplement. Cells were lysed, and luciferase activity 
determined as described in the legend to Figure 1.  Values are the averages +/- SEM of 
quadruplicate determinations. Four independent experiments were conducted. 
 
Figure 10.   Chronic and Acute Effects of PGE1 on the Na,K-ATPase  A) Chronic Effect 
of PGE1 on the level of the Na,K-ATPase in Primary RPT Cell Cultures.  Primary RPT 
cell cultures were grown to confluence in Medium RK-1 in the presence of 10 -6 M 
indomethacin.  Subsequently, the cultures were maintained for 4 days in Medium RK-1 
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containing 10-6 M indomethacin further supplemented either in the presence or the 
absence of 0.7  µM PGE1.  The medium was changed daily. At the end of the 4 day 
incubation, the level of the α and ß subunit of the Na,K-ATPase was determined by 
Western analysis.  The level of α and β subunit mRNA was determined by RealTime 
PCR.  A) Blots of the α and ß subunits as well as beta actin are illustrated.  B) The results 
of scanning densitometry of α and β blots. Values are averages of duplicate 
determinations.  C) The results of determinations of α and β subunit mRNA are shown. 
Values are averages +/- SEM of triplicate determinations. D) The initial rate of Rb+ 
uptake was determined both in the presence and in the absence of 1 mM ouabain. Prior to 
the uptake study, the primary RPT monolayers were maintained for 4 days in DME/F12 
supplemented with 5 µg/ml insulin, 5 µg/ml transferrin, 10-6 M indomethacin, and either 
0.7 µM PGE1 or no further supplement (Control). The difference between total Rb+ 
uptake, and ouabain-insensitive Rb+ uptake (the ouabain-sensitive component) was then 
calculated. Values are averages (+/- SEM) of triplicate determinations.  E)  The activity 
of the Na,K-ATPase in cell lysates was determined in primary RPTs monolayers which 
were maintained for 4 days in DME/F12 supplemented with 5 µg/ml insulin, 5 µg/ml 
transferrin, 10-6 M indomethacin and either 1) 0.35 µM PGE1 and 0.125 mM IBMX, 2) 
0.125 mM IBMX alone, or 3) no further supplement (Control).  Values are averages (+/- 
SEM) of triplicate determinations. 
 
Figure 11.  Acute Effect of PGE1 on the α Subunit.  A. Primary RPT cells on transwell 
membranes were cultured in Medium RK-1 containing 1  µM indomethacin. Following a 
30 min incubation with either 1.4 µM PGE1, 50 µM butaprost or 50 µM 17-phenyltrinor 
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PGE2, the basolateral surface of the primary RPT cells was biotinylated. Samples were 
precipitated using streptavidin beads, separated by SDS-PAGE, and transferred to 
nitrocellulose.  The level of the α subunit of the Na,K-ATPase was determined by 
Western analysis, as described in Materials and Methods.  B.  Primary RPT cells in 35 
mm dishes were cultured in Medium RK-1 containing 1 µM indomethacin.  The 
monolayers were incubated for 30 minutes at 23o C with either 1.4 µM PGE1, 0.125 mM 
IBMX, 1.4 µM PGE1 + 0.125 mM IBMX or no further supplement (Control), followed 
by a 15 min 86Rb+ uptake period, as described in Materials and Methods. Values are 
averages of triplicate determinations +/- SEM. 
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